BetterScholar BetterScholar
10
Role
Title
Level Year L/R
🐒 Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors.
8 auth. M. Marty, P. Fumoleau, A. Adenis, Y. Rousseau, Y. Merrouche, G. Robinet, ... J. Senac, C. Puozzo
7 2001
7
🐒
🐒 I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients
L. Nguyen, D. Fuller, S. Lennon, F. LΓ©ger, C. Puozzo
7 2004
7
🐒
🐜 Dose-Ranging Study of Metronomic Oral Vinorelbine in Patients with Advanced Refractory Cancer
8 auth. E. Briasoulis, P. Pappas, C. Puozzo, C. Tolis, G. Fountzilas, U. Dafni, ... M. Marselos, N. Pavlidis
6 2009
6
🐜
🐜 Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring.
17 auth. J. Gaziev, L. Nguyen, C. Puozzo, A. Mozzi, Marialuisa Casella, M. Perrone Donnorso, P. Gravina, P. Sodani, M. Marziali, A. IsgroΜ€, ... M. D. Simone, M. Andreani, A. Formosa, M. Testi, G. Federici, S. Bernardini, G. Lucarelli
6 2010
6
🐜
🐒 Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
L. Nguyen, F. LΓ©ger, S. Lennon, C. Puozzo
6 2005
6
🐒
🦁 Pharmacokinetics of milnacipran in comparison with other antidepressants
C. Puozzo, B. Leonard
6 1996
6
🦁
🐒 Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring
12 auth. G. Vassal, G. Michel, H. Esperou, J. Gentet, D. Valteau-Couanet, F. Doz, ... F. Mechinaud, C. Galambrun, B. Neven, H. Zouabi, L. Nguyen, C. Puozzo
6 2007
6
🐒
🐜 Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours.
10 auth. J.J.E.M. Kitzen, Maja J.A. de Jonge, C. Lamers, F. Eskens, D. Biessen, L. Doorn, ... J. T. Steeg, M. Brandely, C. Puozzo, Jaap Verweij
6 2009
6
🐜
🐜 Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumours.
8 auth. J. Bennouna, P. Fumoleau, J. Armand, Eric Raymond, M. Campone, F. Delgado, ... C. Puozzo, Michel Marty
6 2003
6
🐜
🦁 Pharmacology and pharmacokinetics of milnacipran
C. Puozzo, E. Panconi, D. Deprez
6 2002
6
🦁